IE34966L - Pharmaceutical composition containing substitiuted¹biguanides - Google Patents

Pharmaceutical composition containing substitiuted¹biguanides

Info

Publication number
IE34966L
IE34966L IE710227A IE22771A IE34966L IE 34966 L IE34966 L IE 34966L IE 710227 A IE710227 A IE 710227A IE 22771 A IE22771 A IE 22771A IE 34966 L IE34966 L IE 34966L
Authority
IE
Ireland
Prior art keywords
pharmaceutical composition
composition containing
pharmaceutical
composition
Prior art date
Application number
IE710227A
Other versions
IE34966B1 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IE34966L publication Critical patent/IE34966L/en
Publication of IE34966B1 publication Critical patent/IE34966B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE227/71A 1970-03-03 1971-02-23 The pharmaceutical use of certain substituted biguanides IE34966B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702009743 DE2009743A1 (en) 1970-03-03 1970-03-03 Substituted biguanides with antihyperglycemic effects

Publications (2)

Publication Number Publication Date
IE34966L true IE34966L (en) 1971-09-03
IE34966B1 IE34966B1 (en) 1975-10-01

Family

ID=5763819

Family Applications (1)

Application Number Title Priority Date Filing Date
IE227/71A IE34966B1 (en) 1970-03-03 1971-02-23 The pharmaceutical use of certain substituted biguanides

Country Status (11)

Country Link
AT (1) AT302350B (en)
BE (1) BE763725A (en)
CH (2) CH553756A (en)
DE (1) DE2009743A1 (en)
ES (2) ES388863A1 (en)
FR (1) FR2085665B1 (en)
GB (1) GB1343831A (en)
IE (1) IE34966B1 (en)
IL (1) IL36271A0 (en)
NL (1) NL7102612A (en)
ZA (1) ZA711269B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064664C (en) * 1991-04-05 2000-01-11 Hiroshi Ishikawa Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives
DE122010000020I1 (en) 1996-04-25 2010-07-08 Prosidion Ltd Method for lowering the blood glucose level in mammals
DE19828113A1 (en) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs of Dipeptidyl Peptidase IV Inhibitors
DE19828114A1 (en) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs of unstable inhibitors of dipeptidyl peptidase IV
DE19834591A1 (en) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Use of substances that decrease the activity of dipeptidyl peptidase IV to increase blood sugar levels, e.g. for treating hypoglycemia
DE19926233C1 (en) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Production of thiazolidine, useful as pharmaceutical intermediate, comprises reacting hexamethylenetetramine with cysteamine
EP2266665B1 (en) 2000-03-31 2016-05-11 Royalty Pharma Collection Trust Method for the improvement of islet signaling in diabetes mellitus and for its prevention
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
FR2822464B1 (en) 2001-03-21 2004-08-06 Lipha BIGUANIDE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
DE10150203A1 (en) 2001-10-12 2003-04-17 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitor in treatment of cancer
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
MXPA04008278A (en) 2002-02-28 2005-09-20 Prosidion Ltd Glutaminyl based dpiv inhibitors.
US6911457B2 (en) 2002-04-11 2005-06-28 Carbomer, Inc. Diabetes imaging probes
DK2206496T3 (en) 2003-05-05 2014-12-15 Probiodrug Ag Screening of inhibitors of pyroglutamic acid formation in amyloid beta peptide
DE602004026289D1 (en) 2003-05-05 2010-05-12 Probiodrug Ag Glutaminyl INHIBITORS
KR101099206B1 (en) 2004-02-05 2011-12-27 프로비오드룩 아게 Novel Inhibitors of Glutaminyl Cyclase
CN110615886A (en) * 2019-09-05 2019-12-27 哈尔滨工程大学 Biguanide derivative antibacterial epoxy resin curing agent and preparation method thereof
CN115960018B (en) * 2022-12-19 2024-01-05 湖南岳靶生物医药有限公司 EGFR inhibitor, composition and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR940304A (en) * 1946-01-07 1948-12-09 Ici Ltd Manufacturing process for biguanide derivatives
FR1053761A (en) * 1949-01-31 1954-02-04 Ici Ltd Manufacture of biguanide derivatives
NL273482A (en) * 1961-01-18
FR6786M (en) * 1967-08-10 1969-03-17

Also Published As

Publication number Publication date
FR2085665A1 (en) 1971-12-31
ZA711269B (en) 1971-11-24
DE2009743A1 (en) 1971-09-16
IE34966B1 (en) 1975-10-01
AT302350B (en) 1972-10-10
IL36271A0 (en) 1971-04-28
NL7102612A (en) 1971-09-07
CH553756A (en) 1974-09-13
FR2085665B1 (en) 1974-08-30
CH564526A5 (en) 1975-07-31
ES391629A1 (en) 1974-09-16
ES388863A1 (en) 1973-06-01
GB1343831A (en) 1974-01-16
BE763725A (en) 1971-09-03

Similar Documents

Publication Publication Date Title
IE34966L (en) Pharmaceutical composition containing substitiuted¹biguanides
ZA713539B (en) Pharmaceutical compositions
ZA717083B (en) New pharmaceutical compositions
MY7700200A (en) Pharmaceutical compositions
IE35991L (en) Camphor-containing pharmaceutical composition
CY955A (en) Pharmaceutical compositions
IL37598A0 (en) Bis-chromonyloxy compounds,their preparation and pharmaceutical compositions containing them
ZA717345B (en) Pharmaceutical preparation
ZA716213B (en) Clear liquid laxative-antacid composition
ZA718014B (en) Pharmaceutical formulations
IL36967A (en) Compositions containing m-tyrisone
CA960966A (en) Pharmaceutical compositions containing melatonin
IE35910B1 (en) Pharmaceutical composition
ZA713877B (en) Pharmaceutical composition
IL38375A0 (en) Pharmaceutical compositions containing pregnane compounds
GB1373913A (en) Pharmaceutical compositions
ZA715832B (en) Pharmaceutical compositions
ZA716461B (en) Pharmaceutical compositions
ZA712071B (en) Pharmaceutical compositions containing viquidil
ZA721363B (en) Pharmaceutical composition
ZA714076B (en) Pharmaceutical preparation
IE35716L (en) Pharmaceutical composition
IL37233A (en) Pharmaceutical preparatuons containing 1-methyl-4nitro -pyrrole-2-carboxaldehyde thisemicabarzone
ZA713227B (en) Pharmaceutical preparation
ZA718200B (en) Pharmaceutical compositions